Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Kidokoro

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Shock (Augusta, Ga.)|November 5, 2002
High-dose antithrombin therapy for sepsis: mechanisms of actionToshiaki Iba, Akio Kidokoro
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 17, 2003
[Disseminated intravascular coagulation]Toshiaki Iba, Akio Kidokoro
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2004
[Activated protein C (the impact of PROWESS trial)]Toshiaki Iba, Akio Kidokoro
Shock (Augusta, Ga.)|November 17, 2004
What can we learn from the three megatrials using anticoagulants in severe sepsis?Toshiaki Iba, Akio Kidokoro
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 17, 2012
[Expression of allergic reactions to oxaliplatin]Daisuke Arii, Yohei Ikeno, Kunihiko Murooka, et al.
The Journal of Trauma|September 23, 2003
Antithrombin modulates the leukocyte-endothelial cell interaction in the staphylococcal enterotoxin B-challenged mouseToshiaki Iba, Akio Kidokoro, M Fukunaga, et al.
Shock (Augusta, Ga.)|October 19, 2006
Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in miceToshiaki Iba, Akio Kidokoro, Masaki Fukunaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 12, 2014
[Verification of reduction in preparation time and cost of cyclophosphamide when using the closed-system drug transfer device]Yohei Ikeno, Daisuke Arii, Hirofumi Nakajima, et al.
International Journal of Clinical Oncology|November 19, 2004
The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancerToshiaki Iba, Akio Kidokoro, Masaki Fukunaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 10, 2004
[Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer]Toshiaki Iba, Akio Kidokoro, Masaki Fukunaga, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Shock (Augusta, Ga.)|November 5, 2002
High-dose antithrombin therapy for sepsis: mechanisms of actionToshiaki Iba, Akio Kidokoro
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 17, 2003
[Disseminated intravascular coagulation]Toshiaki Iba, Akio Kidokoro
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2004
[Activated protein C (the impact of PROWESS trial)]Toshiaki Iba, Akio Kidokoro
Shock (Augusta, Ga.)|November 17, 2004
What can we learn from the three megatrials using anticoagulants in severe sepsis?Toshiaki Iba, Akio Kidokoro
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 17, 2012
[Expression of allergic reactions to oxaliplatin]Daisuke Arii, Yohei Ikeno, Kunihiko Murooka, et al.
The Journal of Trauma|September 23, 2003
Antithrombin modulates the leukocyte-endothelial cell interaction in the staphylococcal enterotoxin B-challenged mouseToshiaki Iba, Akio Kidokoro, M Fukunaga, et al.
Shock (Augusta, Ga.)|October 19, 2006
Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in miceToshiaki Iba, Akio Kidokoro, Masaki Fukunaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 12, 2014
[Verification of reduction in preparation time and cost of cyclophosphamide when using the closed-system drug transfer device]Yohei Ikeno, Daisuke Arii, Hirofumi Nakajima, et al.
International Journal of Clinical Oncology|November 19, 2004
The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancerToshiaki Iba, Akio Kidokoro, Masaki Fukunaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 10, 2004
[Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer]Toshiaki Iba, Akio Kidokoro, Masaki Fukunaga, et al.
Pageof 2